• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

艾滋病相关机会性感染的药物治疗。

Drug treatment of HIV-related opportunistic infections.

作者信息

Klepser M E, Klepser T B

机构信息

Division of Clinical and Administrative Pharmacy, College of Pharmacy, University of Iowa, Iowa City 52242-1112, USA.

出版信息

Drugs. 1997 Jan;53(1):40-73. doi: 10.2165/00003495-199753010-00004.

DOI:10.2165/00003495-199753010-00004
PMID:9010648
Abstract

The AIDS epidemic has led to the emergence of several disease entities which in the pre-AIDS era were rare or seemingly innocuous. Experience of treating these diseases varies. In some instances, such as Pneumocystis carinii pneumonia, there is an abundance of published literature to direct our course of action. However, for many of these newly recognised diseases our treatment experience is limited. Furthermore, in many instances, well controlled trials evaluating treatment modalities in the AIDS population are lacking. We have identified 13 disease entities (P. carinii pneumonia, toxoplasmosis, cryptococcosis, histoplasmosis, Mycobacterium tuberculosis, Mycobacterium avium complex, cytomegalovirus, coccidioidomycosis, isosporiasis, candidosis, Kaposi's sarcoma, herpes simplex virus, and varicella zoster virus) and have reviewed the current literature with regard to their treatment.

摘要

艾滋病流行导致了几种疾病实体的出现,这些疾病在艾滋病出现之前的时代较为罕见或看似无害。治疗这些疾病的经验各不相同。在某些情况下,如卡氏肺孢子虫肺炎,有大量已发表的文献指导我们的治疗行动。然而,对于许多这些新认识的疾病,我们的治疗经验有限。此外,在许多情况下,缺乏评估艾滋病患者治疗方式的严格对照试验。我们确定了13种疾病实体(卡氏肺孢子虫肺炎、弓形虫病、隐球菌病、组织胞浆菌病、结核分枝杆菌、鸟分枝杆菌复合体、巨细胞病毒、球孢子菌病、等孢球虫病、念珠菌病、卡波西肉瘤、单纯疱疹病毒和水痘带状疱疹病毒),并回顾了关于其治疗的当前文献。

相似文献

1
Drug treatment of HIV-related opportunistic infections.艾滋病相关机会性感染的药物治疗。
Drugs. 1997 Jan;53(1):40-73. doi: 10.2165/00003495-199753010-00004.
2
AIDS related opportunistic infections, going but not gone.与艾滋病相关的机会性感染,虽有所改善但仍未消除。
Arch Pharm Res. 2002 Jun;25(3):215-28. doi: 10.1007/BF02976619.
3
AIDS-related infections.艾滋病相关感染
Sci Am. 1990 Aug;263(2):50-7. doi: 10.1038/scientificamerican0890-50.
4
Treatment of infectious complications of acquired immunodeficiency syndrome.获得性免疫缺陷综合征感染性并发症的治疗。
Clin Pharm. 1985 Sep-Oct;4(5):539-54.
5
Preventing and treating major opportunistic infections in AIDS. What's new and what's still true.预防和治疗艾滋病中的主要机会性感染。新进展与仍适用的情况。
Postgrad Med. 1997 Oct;102(4):125-6, 129-35, 139-40. doi: 10.3810/pgm.1997.10.332.
6
HIV: opportunistic infections.人类免疫缺陷病毒:机会性感染。
Clin Evid. 2003 Jun(9):795-816.
7
Opportunistic infections studies update.机会性感染研究进展
NIAID AIDS Agenda. 1995 Spring:6-7.
8
Drugs for AIDS and associated infections.用于治疗艾滋病及相关感染的药物。
Med Lett Drugs Ther. 1995 Oct 13;37(959):87-94.
9
Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America.治疗暴露于HIV和感染HIV儿童的机会性感染:美国疾病控制与预防中心、美国国立卫生研究院及美国传染病学会的建议
MMWR Recomm Rep. 2004 Dec 3;53(RR-14):1-92.
10
Trends in incidence of AIDS illnesses in Australia from 1983 to 1994: the Australian AIDS cohort.1983年至1994年澳大利亚艾滋病相关疾病的发病率趋势:澳大利亚艾滋病队列研究
J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Sep 1;16(1):39-43. doi: 10.1097/00042560-199709010-00006.

引用本文的文献

1
How do people who use drugs receiving Opioid Medication Therapy perceive their treatment ? A multicentre study.接受阿片类药物治疗的药物使用者如何看待他们的治疗?一项多中心研究。
Harm Reduct J. 2022 Mar 28;19(1):31. doi: 10.1186/s12954-022-00608-6.
2
Acute pain management among patients with opioid maintenance therapy: specificities and difficulties identified in primary care: a qualitative study.阿片类药物维持治疗患者的急性疼痛管理:在初级保健中确定的特殊性和困难:一项定性研究。
BMJ Open. 2021 Jan 19;11(1):e044433. doi: 10.1136/bmjopen-2020-044433.
3
The association between age of onset of opioid use and comorbidity among opioid dependent patients receiving methadone maintenance therapy.

本文引用的文献

1
Oral absorption of trimethoprim-sulfamethoxazole in patients with AIDS.艾滋病患者中复方新诺明的口服吸收情况。
Pharmacotherapy. 1996 Jul-Aug;16(4):656-62.
2
Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group.采用每周一次阿奇霉素、每日一次利福布汀或两者联合预防播散性鸟分枝杆菌复合体感染。加利福尼亚协作治疗组。
N Engl J Med. 1996 Aug 8;335(6):392-8. doi: 10.1056/NEJM199608083350604.
3
A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
接受美沙酮维持治疗的阿片类药物依赖患者中,阿片类药物使用起始年龄与共病之间的关联。
Addict Sci Clin Pract. 2017 Mar 28;12(1):9. doi: 10.1186/s13722-017-0074-0.
4
6-Chloro-2-chloro-methyl-4-phenyl-quinazoline 3-oxide.6-氯-2-氯甲基-4-苯基喹唑啉 3-氧化物
Acta Crystallogr Sect E Struct Rep Online. 2014 Mar 15;70(Pt 4):o440-1. doi: 10.1107/S1600536814005303. eCollection 2014 Apr 1.
5
Design, synthesis, and molecular modeling of novel pyrido[2,3-d]pyrimidine analogues as antifolates; application of Buchwald-Hartwig aminations of heterocycles.新型吡啶并[2,3-d]嘧啶类似物的设计、合成与分子建模作为抗叶酸剂;杂环的 Buchwald-Hartwig 胺化反应的应用。
J Med Chem. 2013 Jun 13;56(11):4422-41. doi: 10.1021/jm400086g. Epub 2013 May 21.
6
3-Benzyl-6-methyl-2-sulfanylidene-2,3-di-hydroquinazolin-4(1H)-one.3-苄基-6-甲基-2-硫代亚烷基-2,3-二氢喹唑啉-4(1H)-酮
Acta Crystallogr Sect E Struct Rep Online. 2012 Mar 1;68(Pt 3):o717-8. doi: 10.1107/S1600536812006009. Epub 2012 Feb 17.
7
CoMFA analysis of tgDHFR and rlDHFR based on antifolates with 6-5 fused ring system using the all-orientation search (AOS) routine and a modified cross-validated r(2)-guided region selection (q(2)-GRS) routine and its initial application.基于 6-5 稠合环系统的抗叶酸类化合物的 tgDHFR 和 rlDHFR 的 CoMFA 分析,使用全方向搜索(AOS)程序和改进的交叉验证 r(2)-引导区域选择(q(2)-GRS)程序及其初步应用。
Bioorg Med Chem. 2010 Feb 15;18(4):1684-701. doi: 10.1016/j.bmc.2009.12.066. Epub 2010 Jan 6.
8
2,4-Diamino-5-methyl-6-substituted arylthio-furo[2,3-d]pyrimidines as novel classical and nonclassical antifolates as potential dual thymidylate synthase and dihydrofolate reductase inhibitors.2,4-二氨基-5-甲基-6-取代芳基硫基-呋喃[2,3-d]嘧啶作为新型经典和非经典抗叶酸剂,潜在的胸苷酸合成酶和二氢叶酸还原酶双重抑制剂。
Bioorg Med Chem. 2010 Jan 15;18(2):953-61. doi: 10.1016/j.bmc.2009.11.029. Epub 2009 Dec 26.
9
Design, synthesis, and X-ray crystal structure of classical and nonclassical 2-amino-4-oxo-5-substituted-6-ethylthieno[2,3-d]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors and as potential antitumor agents.经典和非经典的2-氨基-4-氧代-5-取代-6-乙基噻吩并[2,3-d]嘧啶作为胸苷酸合酶和二氢叶酸还原酶双重抑制剂及潜在抗肿瘤药物的设计、合成与X射线晶体结构
J Med Chem. 2009 Aug 13;52(15):4892-902. doi: 10.1021/jm900490a.
10
Potent dual thymidylate synthase and dihydrofolate reductase inhibitors: classical and nonclassical 2-amino-4-oxo-5-arylthio-substituted-6-methylthieno[2,3-d]pyrimidine antifolates.强效双胸苷酸合成酶和二氢叶酸还原酶抑制剂:经典和非经典的2-氨基-4-氧代-5-芳硫基取代-6-甲基噻吩并[2,3-d]嘧啶抗叶酸剂。
J Med Chem. 2008 Sep 25;51(18):5789-97. doi: 10.1021/jm8006933.
两种治疗艾滋病患者鸟分枝杆菌复合群菌血症方案的比较:利福布汀、乙胺丁醇和克拉霉素与利福平、乙胺丁醇、氯法齐明和环丙沙星。加拿大HIV试验网络方案010研究组。
N Engl J Med. 1996 Aug 8;335(6):377-83. doi: 10.1056/NEJM199608083350602.
4
A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome.一项关于克拉霉素预防晚期获得性免疫缺陷综合征患者播散性鸟分枝杆菌复合体感染的随机试验。
N Engl J Med. 1996 Aug 8;335(6):384-91. doi: 10.1056/NEJM199608083350603.
5
Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group.口服更昔洛韦预防艾滋病患者巨细胞病毒病。罗氏协作口服更昔洛韦研究组。
N Engl J Med. 1996 Jun 6;334(23):1491-7. doi: 10.1056/NEJM199606063342302.
6
USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: introduction. USPHS/IDSA Prevention of Opportunistic Infections Working Group.美国公共卫生署/美国感染病学会关于预防感染人类免疫缺陷病毒者机会性感染的指南:引言。美国公共卫生署/美国感染病学会机会性感染预防工作组
Clin Infect Dis. 1995 Aug;21 Suppl 1:S1-11.
7
Randomized, placebo-controlled trial of rifampin, ethambutol, and ciprofloxacin for AIDS patients with disseminated Mycobacterium avium complex infection.利福平、乙胺丁醇和环丙沙星治疗播散性鸟分枝杆菌复合群感染艾滋病患者的随机安慰剂对照试验。
J Infect Dis. 1993 Jul;168(1):112-9. doi: 10.1093/infdis/168.1.112.
8
Salvage trial of trimetrexate-leucovorin for the treatment of cerebral toxoplasmosis in patients with AIDS.三甲曲沙-亚叶酸钙挽救性治疗艾滋病患者脑弓形虫病的试验。
J Infect Dis. 1993 Jun;167(6):1422-6. doi: 10.1093/infdis/167.6.1422.
9
Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS.阿托伐醌(566C80)与甲氧苄啶-磺胺甲恶唑治疗艾滋病患者卡氏肺孢子虫肺炎的比较。
N Engl J Med. 1993 May 27;328(21):1521-7. doi: 10.1056/NEJM199305273282103.
10
Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group.氨苯砜-乙胺嘧啶与雾化喷他脒作为HIV感染患者预防卡氏肺孢子虫肺炎和弓形虫病的一线用药比较。PRIO研究组。
N Engl J Med. 1993 May 27;328(21):1514-20. doi: 10.1056/NEJM199305273282102.